Researcher profile

Donna Coffman

Donna Coffman contributes to research discovery and scholarly infrastructure.

ResearcherAffiliation not importedOpen to collaborate

Trust snapshot

Quick read

Trust 11 - UnverifiedVerification L1Unclaimed author
1works
0followers
1topics
3close collaborators

Actions

Decide how to stay connected

Follow researcher0

Identity and collaboration

How to connect with this researcher

Claiming links this public author record to a researcher profile and unlocks direct collaboration workflows.

Log in to claim

Direct collaboration

Open a focused conversation when the fit is right

Claim this author entity first to unlock direct invitations.

Research graph

See the researcher in context

Open full explorer

Inspect adjacent work, topics, institutions and collaborators without jumping out to a separate graph page.

Building this graph slice

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

1 published item(s)

preprint2020arXiv

Estimating the impact of treatment compliance over time on smoking cessation using data from ecological momentary assessments (EMA)

The Wisconsin Smoker's Health Study (WSHS2) was a longitudinal trial conducted to compare the effectiveness of two commonly used smoking cessation treatments, varenicline and combination nicotine replacement therapy (cNRT) with the less intense standard of care, nicotine patch. The main outcome of the WSHS2 study was that all three treatments had equivalent treatment effects. However, in-depth analysis of the compliance data collected via ecological momentary assessment (EMA) were not analyzed. Compliance to the treatment regimens may represent a confounder as varenicline and cNRT are more intense treatments and would likely have larger treatment effects if all subjects complied. In order to estimate the causal compliance effect, we view the counterfactual, the outcome that would have been observed if the subject was allocated to the treatment counter to the fact, as a missing data problem and proceed to impute the counterfactual. Our contribution to the methodological literature lies in the extension of this idea to a more general analytic approach that includes mediators and confounders of the mediator-outcome relationship. Simulation results suggest that our method works well and application to the WSHS2 data suggest that the treatment effect of nicotine patch, varenicline, and cNRT are equivalent after accounting for differences in treatment compliance.